Brief: Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer
23/06/2025 06:02
June 23 (Reuters) - Novartis AG NOVN.S: NOVARTIS ANNOUNCES EXPIRATION OF HART-SCOTT-RODINO WAITING PERIOD OF REGULUS THERAPEUTICS TENDER OFFER EXPIRATION OF HART-SCOTT-RODINO ACT WAITING PERIOD OCCURRED AT 11:59 P.M., NEW YORK CITY TIME, ON JUNE 20, 2025 Source text: ID:nGNEbw8jxs Further company coverage: NOVN.S ((frankfurt.newsroom@thomsonreuters.com;))
Recent news on Regulus Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Regulus Therapeutics
Brief: Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics
Regulus Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Regulus Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview